We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · October 12, 2021

Comparable Efficacy and Tolerability of Mycophenolate Mofetil vs Methotrexate for Vulvar Lichen Planus

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability
J Am Acad Dermatol 2021 Sep 06;[EPub Ahead of Print], ML Hrin, NL Bowers, SR Feldman, WW Huang, RO Pichardo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading